MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.
about
DARPP-32 mediates the actions of multiple drugs of abuseGlutamatergic modulation of hyperactivity in mice lacking the dopamine transporterMicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunctionAlpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: importance of the balance between the dopamine and serotonin systems.Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors.Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems.Synergistic activity between the delta-opioid agonist SNC80 and amphetamine occurs via a glutamatergic NMDA-receptor dependent mechanism.Effects of Immune Activation during Early or Late Gestation on N-Methyl-d-Aspartate Receptor Measures in Adult Rat Offspring.Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior.Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens.Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress.Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.Developmental vitamin D deficiency alters MK-801-induced behaviours in adult offspring.Vortioxetine Differentially Modulates MK-801-Induced Changes in Visual Signal Detection Task Performance and Locomotor Activity
P2860
Q22241668-63B64614-865C-4AD8-A4D4-17ABB0F8C3CDQ24555193-3BB1D26D-DC68-4E22-8809-2B70B124D919Q24644849-2ED63603-B4B0-4FE5-B7BE-3D5BCE5F44F0Q30467353-533703E1-DC34-4BF2-99F3-D177EA052B9FQ34722921-9E27949B-4A49-4C26-B399-551C1DD8164DQ35678190-B5D03A17-F013-4BF9-8461-4F6A1EEA1113Q37675811-256CAAA7-A7E8-49C2-AC30-284955BF7F30Q41471608-0F0BD2A8-3A59-4BBD-9FB7-C85CDEC5C212Q44259214-AF4B9AE8-2673-43D3-85CF-798C306ED2A7Q44407141-63ECB295-D010-4C20-AD2C-A470EE184064Q44853625-57591AAD-F0FC-4696-BBF3-6E9A85344273Q45248983-29DE254F-D52B-459A-A03B-203D5474684AQ46981597-876E4C39-EA65-4057-9ABA-01E448879309Q48148887-57D024B3-E09C-4B99-989B-F213660130FDQ48565601-4C0C8723-8ED2-4105-8268-37B15722077BQ48616683-ADACFEAA-4D93-4AA2-A783-5E80FC255329Q48879762-4C97A180-4AE9-4022-867E-E9C8BF8F8F5FQ57111051-005D8F57-8E71-41D5-B173-6D408C79355C
P2860
MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
MK-801 increases locomotor act ...... vels in the nucleus accumbens.
@en
MK-801 increases locomotor act ...... vels in the nucleus accumbens.
@nl
type
label
MK-801 increases locomotor act ...... vels in the nucleus accumbens.
@en
MK-801 increases locomotor act ...... vels in the nucleus accumbens.
@nl
prefLabel
MK-801 increases locomotor act ...... vels in the nucleus accumbens.
@en
MK-801 increases locomotor act ...... vels in the nucleus accumbens.
@nl
P2093
P2860
P1433
P1476
MK-801 increases locomotor act ...... vels in the nucleus accumbens.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1098-2396(199610)24:2<135::AID-SYN5>3.0.CO;2-G
P577
1996-10-01T00:00:00Z